Genistein inhibits estradiol- and environmental endocrine disruptor-induced growth effects on neuroblastoma cells in vitro

Zheng,Jicui; Li,Hui; Zhu,Haitao; Xiao,Xianmin; Ma,Yangyang

doi:10.3892/ol.2013.1236

Genistein inhibits estradiol- and environmental endocrine disruptor-induced growth effects on neuroblastoma cells in vitro

Authors:
- Jicui Zheng
- Hui Li
- Haitao Zhu
- Xianmin Xiao
- Yangyang Ma
View Affiliations

Affiliations: Department of Pediatric Surgery, Children's Hospital, Fudan University, Shanghai 201102, P.R. China
Published online on: March 7, 2013 https://doi.org/10.3892/ol.2013.1236
Pages: 1583-1586

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of this study was to examine the effect of genistein on human neuroblastoma cell proliferation induced by two common environmental endocrine disruptors, bisphenol A (BPA) and Di-2-ethylhexyl phthalate (DEHP), and to investigate its underlying mechanism. SK-N-SH human neuroblastoma cells were treated with E2 (1 ng/ml), BPA (2 µg/ml) or DEHP (100 µM), with or without genistein (12.5 µM) in vitro. The number of viable cells was detected with an absorbance reader after 0, 24, 48 or 72 h treatment. The percentage of cells in different phases, and expression of Akt and its phosphorylation levels were also assessed by flow cytometry and western blot analysis at 72 h, respectively. The BPA and DEHP groups had a 30% higher number of viable cells compared to the non-treated group at 48 h (P<0.001). However, the cell numbers did not increase significantly in the groups with additional treatment with genistein (P>0.05 vs. control) and the same trend was observed at 72 h. The expression of phospho-Akt protein was increased in the groups treated with BPA or DEHP compared to the control group at 72 h (P<0.05), while no significant elevation in the expression of phospho-Akt was observed (P>0.05) in genistein-treated groups. Cells were arrested at the G2/M phase by genistein. Similar effects were observed in the E2 group with or without genistein treatment. Akt protein expression had no significant change among all the groups (P>0.05). In conclusion, estradiol- or environmental endocrine disruptor-induced proliferation of human neuroblastoma cells is effectively abolished by genistein, likely in a cell cycle- and Akt pathway-dependent manner.

View Figures

View References

1	van Noesel MM and Versteeg R: Pediatric neuroblastomas: genetic and epigenetic ‘danse macabre’. Gene. 325:1–15. 2004.
2	Izbicka E and Izbicki T: Therapeutic strategies for the treatment of neuroblastoma. Curr Opin Investig Drugs. 6:1200–1214. 2005.PubMed/NCBI
3	DuBois SG, Kalika Y, Lukens JN, et al: Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival. Journal of pediatric hematology/oncology. 21:181–189. 1999. View Article : Google Scholar : PubMed/NCBI
4	Zheng J, Xiao X, Liu J, Zheng S, Yin Q and Yu Y: Growth-promoting effect of environmental endocrine disruptors on human neuroblastoma SK-N-SH cells. Environ Toxicol Pharmacol. 24:189–193. 2007. View Article : Google Scholar : PubMed/NCBI
5	Zhu H, Xiao X, Zheng J, Zheng S, Dong K and Yu Y: Growth-promoting effect of bisphenol A on neuroblastoma in vitro and in vivo. J Pediatr Surg. 44:672–680. 2009. View Article : Google Scholar : PubMed/NCBI
6	De Roos AJ, Olshan AF, Teschke K, et al: Parental occupational exposures to chemicals and incidence of neuroblastoma in offspring. Am J Epidemiol. 154:106–114. 2001.PubMed/NCBI
7	Formica JV and Regelson W: Review of the biology of Quercetin and related bioflavonoids. Food Chem Toxicol. 33:1061–1080. 1995. View Article : Google Scholar : PubMed/NCBI
8	Ismail IA, Kang KS, Lee HA, Kim JW and Sohn YK: Genistein-induced neuronal apoptosis and G2/M cell cycle arrest is associated with MDC1 up-regulation and PLK1 down-regulation. Eur J Pharmacol. 575:12–20. 2007. View Article : Google Scholar : PubMed/NCBI
9	Park OJ and Surh YJ: Chemopreventive potential of epigallocatechin gallate and genistein: evidence from epidemiological and laboratory studies. Toxicol Lett. 150:43–56. 2004. View Article : Google Scholar : PubMed/NCBI
10	Magee PJ and Rowland IR: Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer. Br J Nutr. 91:513–531. 2004. View Article : Google Scholar : PubMed/NCBI
11	Sarkar FH and Li Y: Soy isoflavones and cancer prevention. Cancer investigation. 21:744–757. 2003. View Article : Google Scholar : PubMed/NCBI
12	Hebert JR, Hurley TG, Olendzki BC, Teas J, Ma Y and Hampl JS: Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study. J Natl Cancer Inst. 90:1637–1647. 1998. View Article : Google Scholar : PubMed/NCBI
13	Rannikko A, Petas A, Rannikko S and Adlercreutz H: Plasma and prostate phytoestrogen concentrations in prostate cancer patients after oral phytoestogen supplementation. The Prostate. 66:82–87. 2006. View Article : Google Scholar
14	Li Y and Sarkar FH: Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway. Clin Cancer Res. 8:2369–2377. 2002.PubMed/NCBI
15	Lo FH, Mak NK and Leung KN: Studies on the anti-tumor activities of the soy isoflavone daidzein on murine neuroblastoma cells. Biomed Pharmacother. 61:591–595. 2007. View Article : Google Scholar : PubMed/NCBI
16	Linford NJ, Yang Y, Cook DG and Dorsa DM: Neuronal apoptosis resulting from high doses of the isoflavone genistein: role for calcium and p42/44 mitogen-activated protein kinase. J Pharmacol Exp Ther. 299:67–75. 2001.PubMed/NCBI
17	Hewitt AL and Singletary KW: Soy extract inhibits mammary adenocarcinoma growth in a syngeneic mouse model. Cancer Lett. 192:133–143. 2003. View Article : Google Scholar : PubMed/NCBI
18	Chang KL, Kung ML, Chow NH and Su SJ: Genistein arrests hepatoma cells at G2/M phase: involvement of ATM activation and upregulation of p21waf1/cip1 and Wee1. Biochem Pharmacol. 67:717–726. 2004. View Article : Google Scholar : PubMed/NCBI
19	Sarkar FH, Adsule S, Padhye S, Kulkarni S and Li Y: The role of genistein and synthetic derivatives of isoflavone in cancer prevention and therapy. Mini reviews in medicinal chemistry. 6:401–407. 2006. View Article : Google Scholar : PubMed/NCBI
20	Gong L, Li Y, Nedeljkovic-Kurepa A and Sarkar FH: Inactivation of NF-kappaB by genistein is mediated via Akt signaling pathway in breast cancer cells. Oncogene. 22:4702–4709. 2003. View Article : Google Scholar : PubMed/NCBI
21	Park SS, Kim YN, Jeon YK, et al: Genistein-induced apoptosis via Akt signaling pathway in anaplastic large-cell lymphoma. Cancer chemother Pharmacol. 56:271–278. 2005. View Article : Google Scholar : PubMed/NCBI